Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Stryker Recall News: Product Liability Attorneys Caution Hip Replacement Patients to Avoid Signing Stryker’s Settlement Agreements without Consulting an Attorney
  • USA - English


News provided by

Kershaw, Cutter & Ratinoff

Feb 15, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Given the kind of pain and suffering experienced during a Stryker revision surgery, they are essentially offering pennies on the dollar.

Post this

(PRWEB) February 15, 2014 -- Recently there have been reports that Stryker, through Broadspire Services, Inc., is attempting to obtain releases from unrepresented individuals allegedly injured by the Stryker Rejuvenate and ABG II hip systems in an effort to settle their cases. This is a stark departure from Broadspire’s previous practice of paying individuals for their “out-of-pocket” expenses, without requiring a release of any claims. This recent tactic is disturbing to many plaintiff’s lawyers since many unrepresented individuals may not fully understand the legal ramifications of their actions or the numerous pit falls that can occur if a settlement is not done correctly. Civil Justice Attorneys at Kershaw-Talley are urging patients not to sign any document from Broadspire without first consulting with an attorney.

One of the biggest concerns, according to legal experts, is that the amounts being offered by Broadspire and Stryker are well below what would be considered fair compensation. Product liability attorney, Stuart Talley warns, “We have received several calls from unrepresented individuals who were seeking advice about settlement offers being made by Broadspire. When I heard the amounts being offered, I was shocked. Given the kind of pain and suffering experienced during a Stryker revision surgery, they are essentially offering pennies on the dollar.” Talley also cautions that the settlement process can be extremely complicated and that, without a lawyer, irreversible errors could be made that may result in a patient receiving nothing or much less than they expect.

There is a long list of potential pitfalls consumers may not be aware of. Here is one critical risk factor. Hip replacement patients need to know that MediCare and private health insurance companies hold liens on their litigation. What this means is that the insurance carrier, by law, is entitled to be reimbursed from any settlement paid to a patient for the entire cost of the revision surgery and subsequent treatment. In some cases, these liens can exceed $100,000. If the liens are not paid at the time of settlement, the hip patient could end up being personally liable for the entire cost of the replacement surgery. This could come as a huge blow to most plaintiffs and could end up dramatically reducing or completely eliminating a patient’s settlement award.

Here’s an example. If a patient settles their case with Stryker for $225,000 and it turns out that MediCare paid $300,000 to cover the patient’s revision surgery, as well as subsequent treatments, the hip patient could be personally liable to MediCare for the entire $225,000. This means that the settlement recipient would end up receiving nothing from the settlement.

Talley further cautions hip patients on another critical factor. Any settlement deal with Broadspire will be final and will eliminate any rights to file a claim should hip problems present themselves in the future. “In order to settle your case, Stryker will insist that you sign a ‘release.’ A ‘release’ is a formal legal document where you agree to give up all of your rights to sue Stryker for any issues related to your failed hip.” This is important to understand especially if a hip patient has recently had revision surgery. Affected hip recipients do not want to settle their case until they’re confident their hip has fully recovered from surgery. For example, one unrepresented patient contacted Talley to seek advice on a potential settlement offer from Stryker. However, the patient had just had her revision surgery 2 months previously and was still recovering from that surgery. “There are a significant number of unfortunate circumstances that can occur after revision surgery and sometimes these challenges don’t present themselves until months later. We’ve seen patients suffering from infections, nerve damage, or bone fractures that in some cases occurred up to a year after surgery. If you sign a release too early and problems arise down the road, you will not be able to obtain any additional compensation from Stryker. You are essentially on your own.”

Now trial watchers may recall that Johnson & Johnson’s DePuy Orthopaedics Inc. unit hired Broadspire to manage the company’s mounting claims and out-of-pocket expenses associated with alleged defective hip cases in 2011. According to an August, 2011 Reuters report, industry critics and legal experts argued that the strategy was designed to limit settlement payments, while gaining access to medical records and other private data that could be used against patients in court. Johnson & Johnson maintained that it was an efficient way to process thousands of claims.

Stryker followed suit in partnering with Broadspire after its Rejuvenate and ABG II hip replacement systems were recalled in July of 2013. FDA reports indicated that the devices were prone to fretting and corrosion, causing metal toxicity in some patients. More than 20,000 prosthetic Stryker Rejuvenate and ABG II hips were surgically implanted into patients nationwide between 2008 and 2012. Both models are reporting alarmingly high failure rates.

The law services of Kershaw-Talley maintain the Defective Hip Settlement Center resource at http://www.defectivehipsettlementcenter.com for hip patients seeking information about how to file a Stryker lawsuit. The resource center also provides critical trial updates on its Stryker Hip Recall Litigation Update page specifically created to field questions and offer free legal advice to affected hip patients across the country. Individuals who may have been impacted by Stryker’s hip systems may be entitled to receive compensation for loss of wages, medical bills, pain and suffering.

The legal team of Kershaw-Talley is a Sacramento-based firm that represents individuals nationwide in defective medical device cases, generating hundreds of millions of dollars in recoveries for their clients and the classes they represent. For a free case evaluation and more information about the status of the case, call Stuart Talley directly at (888) 997-3152 or log onto http://www.defectivehipsettlementcenter.com.

Candice Danielle, Kershaw, Cutter & Ratinoff, http://www.kcrlegal.com, +1 888 997-3152, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.